TheAnswerPage

JANUARY 11, 2022

Are you able to answer your patients’ medical marijuana questions? and ‘The Perioperative Considerations for the Patient Utilizing Cannabinoid-based Medicines and Products.’ million medical marijuana patients nationwide. Written by Dr. Meredith Fisher-Corn, MD , Editor-in-Chief at TheAnswerPage.com.

Patients 98

Patients Education Marijuana Therapy 98

Cannabis Law Report

SEPTEMBER 11, 2021

The nature of the position involves designing application receipt and review processes, review of detailed license and renewal applications, preparation of complaints cases for investigations, preparation of investigations cases for disposition, and oversight of vendor data systems for complex laboratory, seed-to-sale tracking, and complaints.

Compliance 105

Compliance Compliance Seed-To-Sale Data 105

Cannabis Law Report

SEPTEMBER 1, 2021

This number also underscores the entire agency’s tireless efforts, particularly those of our hardworking staff, to thoughtfully regulate a safe, accessible, and effective adult-use marketplace that keeps critical tenets of our mission – public health, public safety, and equity, among others – front of mind.”.

Marijuana 100

Marijuana Seed-To-Sale Safety Data 100

MMJ Recs

NOVEMBER 17, 2023

This article explores the profound impact of MMJ on Maryland communities, shedding light on the medical marijuana benefits experienced by patients and the positive effects it has had on the state’s communities. It has improved the quality of life for those dealing with chronic pain, nausea, seizures, and other medical conditions.

Chronic Pain 98

Chronic Pain Therapy Research and Development Treatment 98

MMJ Recs

MARCH 16, 2024

Regulations vary significantly by jurisdiction but typically encompass licensing requirements, product safety standards, and distribution protocols. Key factors influencing market size and revenue include patient demographics, regulatory frameworks, product offerings, and pricing strategies.

Supply Chain 105

Supply Chain Research and Development Marijuana Seed-To-Sale 105

Cannabis Law Report

JUNE 16, 2021

Both parties to this new relationship are committed to excellence in clinical research and patient access to psychedelic medicine with a focus on naturally derived psilocybin. This engagement will build on the strong foundation on Santé, having treated more than 10,000 patients since 2014 under a real-world data protocol.

Clinical Trials 104

Clinical Trials Therapy Research and Development Events 104

Cannabis Law Report

MARCH 17, 2022

Metrc will implement its robust track-and-trace platform to help facilitate the Minnesota Medical Cannabis Program’s data collection and regulatory oversight. ” Metrc now holds exclusive government contracts in every region of the U.S, including Alaska , California , and Washington, D.C. .

Data 52

Data Compliance Compliance Programs 52

Cannabis Law Report

AUGUST 16, 2022

Seamless data tracking helps operators optimize inventory control, accurately report sales data, and improve cultivation management. As Alabama works to solidify its medical cannabis program, we are thrilled to have the opportunity to spearhead the state’s first-ever track-and-trace program,” said Michael Johnson, CEO at Metrc.

Seed-To-Sale 52

Seed-To-Sale Supply Chain Data Patients 52

Cannabis Law Report

JUNE 15, 2021

The nature of the position involves designing application receipt and review processes, review of detailed license and renewal applications, preparation of complaints cases for investigations, preparation of investigations cases for disposition, and oversight of vendor data systems for complex laboratory, seed-to-sale tracking, and complaints.

Compliance 105

Compliance Compliance Seed-To-Sale Data 105

Veriheal

AUGUST 3, 2021

Under the terms of the legislation, House Bill 1024 will extend cannabis curbside services and indefinitely eradicate the patient cap for actively serving caregivers. In addition to this, patients will be given the opportunity to acquire a 90-day supply of cannabis. Previously, registered patients were limited to a 30-day supply.

Legislation 98

Legislation Patients Supply Chain Dispensary 98

Cannabis Law Report

JULY 22, 2022

As the only track-and-trace company to have successfully taken over a government contract from another vendor, Metrc will replace the State’s current partner and implement its robust track-and-trace platform to help facilitate the Rhode Island Medical Cannabis Program’s data collection and regulatory oversight. and now Rhode Island.

Data 52

Data Programs Access Compliance 52

Cannabis Law Report

JULY 11, 2019

Board Certification – Effective May 7, 2019, SB 162 removed the requirement for physicians issuing recommendations to patients for medical marijuana to be board certified. OMMA is currently evaluating implementation timelines for this data infrastructure. If approved, the patient would then have to pay $100 to obtain that license.

Legislation 55

Legislation Programs Seed-To-Sale Marijuana 55

SpeedWeed

MARCH 6, 2021

Public safety at issue. Proponents of these THC caps—who are often the same politicians who stood against legalization and lost—contend that limiting THC levels will increase public safety. Forcing patients to purchase more. Doing so, Pollara wrote, would effectively force a 50% to 150% tax on patients.

THC 52

THC Patients Law Chronic Pain 52

Cannabis Law Report

APRIL 5, 2022

Metrc will help facilitate Mississippi’s medical cannabis program’s data collection and regulatory oversight through its robust track-and-trace platform. State regulators can also conveniently access this same information, which will be essential in creating a safe and secure marketplace for both patients and providers. “We

Safety 52

Safety Patients Dispensary Compliance 52

Cannabis Law Report

SEPTEMBER 18, 2021

The nature of the position involves designing application receipt and review processes, review of detailed license and renewal applications, preparation of complaints cases for investigations, preparation of investigations cases for disposition, and oversight of vendor data systems for complex laboratory, seed-to-sale tracking, and complaints.

Compliance 52

Compliance Compliance Seed-To-Sale Data 52

Cannabis Law Report

JANUARY 31, 2022

This list is available by request to those seeking access to psilocybin through the Special Access Program (SAP), and clinical researchers. These doses are produced under Good Agricultural and Collection Practices and tested for potency and impurities to support patient safety and practitioner confidence.

Research and Development 52

Research and Development Clinical Trials Packaging Access 52

Cannabis Law Report

JUNE 17, 2022

status as a medical cannabis program patient,” or. The bill’s protections do not extend to employees whose “position is designated as safety sensitive.” Both the use of cannabis for adults and for patients is permitted in the District of Columbia.

Safety 52

Safety Legislation Policy Cannabis 52

Cannabis Law Report

SEPTEMBER 15, 2021

This deceptive marketing of unproven treatments raises significant public health concerns because patients and other consumers may use them instead of approved therapies to treat serious and even fatal diseases. Of the 22 patients, 19 experienced adverse events after ingesting delta-8 THC-containing food products (e.g.,

THC 105

THC Pets Events Hemp 105

Cannabis Law Report

SEPTEMBER 29, 2021

With more states legalizing cannabis for medical and recreational use, TCI recognizes the critical role that education plays in reducing patient adverse outcomes and ensuring the safe use of cannabis. TCI was founded by Drs. TCI offers cannabis medical education in both English and Spanish. About Dr. Jan Roberts ?

Cannabinoids 52

Cannabinoids Education Patients Safety 52

Veriheal

AUGUST 31, 2020

Program between St. Essay Summary: Nishtha wants to further research into THC treatment for patients suffering from neurodegenerative diseases like Alzheimer’s and epilepsy , both of which cause neuron death. She is entering the 8-year Dual Admit B.S./M.D. Bonaventure University and George Washington University School of Medicine. .

Research and Development 117

Research and Development Education Agriculture Patients 117

Cannabis Law Report

DECEMBER 26, 2021

In furtherance of its program, the Company filed US Provisional Patent Application No. “Entheon is proud to be making significant strides in its Entheon IQ™ program,” says Timothy Ko, Chief Executive Officer of Entheon. US Provisional Patent Filed. ” In Vivo Toxicity Assays Completed.

Research and Development 52

Research and Development Clinical Trials Treatment Packaging 52

Cannabis Law Report

JUNE 9, 2021

The nature of the position involves designing application receipt and review processes, review of detailed license and renewal applications, preparation of complaints cases for investigations, preparation of investigations cases for disposition, and oversight of vendor data systems for complex laboratory, seed-to-sale tracking, and complaints.

Compliance 66

Compliance Compliance Seed-To-Sale Data 66

Cannabis Law Report

AUGUST 17, 2021

reduction in 28-day seizure frequency relative to baseline in tuberous sclerosis complex (TSC) patients (n=23). reduction was observed in focal seizures (n=19), the most common seizure type in TSC patients. Phase 3 planning for TrustTSC trial ongoing with first patient expected to be enrolled in Q4 2021. Data Highlights.

Pharmaceutical 98

Pharmaceutical Clinical Trials Treatment Patients 98

Cannabis Law Report

JANUARY 24, 2022

Company is on track to announce interim data in mid-2022 from its Phase 2 clinical trial for lead kidney precision medicine product candidate GFB-887. Dr. Tucker has successfully advanced several programs through clinical development and regulatory approval. CAMBRIDGE, Mass.–(BUSINESS

Clinical Trials 52

Clinical Trials Research and Development Data Medicine 52

Cannabis Law Report

OCTOBER 21, 2021

adults shows broad support for securely labeling cannabis products to verify their legitimacy and safety in the marketplace. Ensuring the safety of cannabis products is top of mind for Americans. Four in five Americans (80% ) voiced their support for a program that would make it easier to detect legal vs. illegal cannabis products.

Safety 52

Safety Research and Development Compliance Compliance 52

Cannabis Law Report

OCTOBER 22, 2021

To date, more than 50 novel compounds have been evaluated through collaborations with experienced contract research organizations for pharmacokinetic/pharmacodynamic profile, metabolic stability, receptor binding, and safety in order to identify preferred candidates for further development.

Research and Development 52

Research and Development Safety Media Data 52

Cannabis Law Report

JUNE 6, 2022

has made regulatory and market functionality elusive for most cannabis businesses and the patients and consumers they serve. What modifications can be made to existing frameworks to meet government and industry goals for equity, public health and safety and economic opportunity?

Policy 52

Policy Hemp Education Compliance 52

MMJ Recs

FEBRUARY 23, 2024

The foundational framework was laid with the establishment of the Michigan Medical Marijuana Program in 2008, signalling the state’s commitment to providing legal access to cannabis for qualified patients. Patients benefit from a broad spectrum of cannabis products addressing various medical conditions.

Marijuana 52

Marijuana Dispensary Supply Chain Research and Development 52

Cannabis Law Report

NOVEMBER 6, 2019

Developing our Responsible Vendor Training Program , which will support licensee compliance and enhance the safety of customers and employees of cannabis businesses in the Commonwealth.

Research and Development 45

Research and Development Programs Education Compliance 45

Veriheal

APRIL 11, 2022

He also emphasized the fact that medical cannabis programs are now legal in 37 states, as well as four out of five inhabited U.S. You don’t take that opium poppy and ask a patient to rub it on their lip for morphine. territories. This means that U.S. Challenges in Conducting Medical Cannabis Research Remain. federal law.

Pharmaceutical 104

Pharmaceutical Research and Development DEA Clinical Trials 104

The Cannigma

JULY 1, 2022

Research funding is also up, and all of this data influences how we see, think and hear about the plant and its effects. These claims influence things like how consumers purchase cannabis or how doctors consult with medical cannabis patients. Recent data suggest the US science knowledge is about the global average.

Research and Development 108

Research and Development Data THC Clinical Trials 108

Cannabis Law Report

SEPTEMBER 23, 2021

BIMA was an Open-label safety, tolerability and proof-of-concept study to investigate the role of MDMA-Assisted Psychotherapy in treating patients with alcohol use disorder (AUD). This data will assist Awakn’s progress by enabling a better design and more efficient execution of its clinical program.

Research and Development 52

Research and Development Therapy Treatment Data 52

SpeedWeed

APRIL 29, 2021

We will continue to prioritize creating a positive, supportive and inclusive work environment for all team members and provide our patients and customers with the excellent service they expect and deserve from Curaleaf.”. increase from 2019, according to adult-use sales and production data from the state’s Cannabis Control Commission.

Programs 52

Programs Seed-To-Sale Dispensary Cultivation 52

SpeedWeed

JULY 25, 2021

‍ According to the Atlanta Journal Constitution , the next steps in the medical marijuana program will be finalizing contracts with the six winning companies, then starting operations next year. Ed Keating is a co-founder of Cannabiz Media and oversees the company’s data research and government relations efforts.

Media 52

Media Data Dispensary Access 52

Cannabis Law Report

JULY 29, 2021

Tetra Bio-Pharma ( TSX: TBP ) ( OTCQB: TBPMF ) ( FRA:JAM1 ) is a leader in cannabinoid-derived drug discovery and development with a FDA and a Health Canada cleared clinical program aimed at bringing novel prescription drugs and treatments to patients and their healthcare providers. For more information visit: www.tetrabiopharma.com.

Research and Development 105

Research and Development Clinical Trials Events Cannabinoids 105

SpeedWeed

APRIL 21, 2021

You cannot read a cannabis industry newsletter these days without seeing articles that hype the future impact of New York, New Jersey, Virginia, and New Mexico adult use programs. It even affects the stock prices of the Canadian licensed producers because the uninitiated believe these companies will benefit from new US programs.

Programs 52

Programs Dispensary Oil Cultivation 52

Marijuana Lawyer Blog

FEBRUARY 9, 2020

Since its passing in 2016, Prop 64 has earmarked its entire cannabis industry tax revenue, minus regulatory costs, to supporting public health, repairing the environment, and bettering public safety. 20 percent to public safety initiatives. million in grants to support public health and safety initiatives.

Marijuana 64

Marijuana Safety Programs Dispensary 64